MAPK3 and Alzheimer disease: On the other hand, recent studies have shown that the MEK–ERK1/2 signaling pathway is also a contributor to other pathophysiological processes of AD, including VSMC phenotype switch39, apoptosis40, and proliferation inhibition41.